Pharma & Healthcare
Global Codeine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 28, 25
- ID: 341049
- Pages: 159
- Figures: 151
- Views: 1
In 2024, the global market size of Codeine was estimated to be worth US$ 244 million and is forecast to reach approximately US$ 165 million by 2031 with a CAGR of -5.5% during the forecast period 2025-2031.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Codeine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine.
The Codeine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Codeine market comprehensively. Regional market sizes, concerning products by Ingredient, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Codeine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Ingredient, by Application, and regions.
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Ingredient
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Ingredient and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Codeine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Codeine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Codeine sales, revenue, price, gross margin, sales by region, by Ingredient, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Ingredient, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Ingredient, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Ingredient, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Ingredient, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Ingredient, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Ingredient, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Codeine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine.
The Codeine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Codeine market comprehensively. Regional market sizes, concerning products by Ingredient, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Codeine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Ingredient, by Application, and regions.
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Ingredient
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Ingredient and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Codeine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Codeine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Codeine sales, revenue, price, gross margin, sales by region, by Ingredient, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Ingredient, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Ingredient, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Ingredient, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Ingredient, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Ingredient, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Ingredient, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Codeine Product Introduction
1.2 Market by Ingredient
1.2.1 Global Codeine Market Size Growth Rate by Ingredient (2020 VS 2024 VS 2031)
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Market by Application
1.3.1 Global Codeine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Codeine Market Size Estimates and Forecasts
2.1.1 Global Codeine Revenue 2020-2031
2.1.2 Global Codeine Sales 2020-2031
2.2 Codeine Market Size by Region: 2024 Versus 2031
2.3 Codeine Sales by Region (2020-2031)
2.3.1 Global Codeine Sales by Region: 2020-2025
2.3.2 Global Codeine Sales Forecast by Region (2026-2031)
2.3.3 Global Codeine Sales Market Share by Region (2020-2031)
2.4 Codeine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Codeine Revenue by Region: 2020-2025
2.4.2 Global Codeine Revenue Forecast by Region (2026-2031)
2.4.3 Global Codeine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Ingredient
3.1.1 Global Codeine Sales by Ingredient (2020-2031)
3.1.1.1 Global Codeine Sales Volume by Ingredient (2020-2031)
3.1.1.2 Global Codeine Sales Market Share by Ingredient (2020-2031)
3.1.2 Global Codeine Revenue by Ingredient (2020-2031)
3.1.2.1 Global Codeine Revenue by Ingredient (2020-2031)
3.1.2.2 Global Codeine Revenue Market Share by Ingredient (2020-2031)
3.1.3 Codeine Average Selling Price (ASP) by Ingredient (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Codeine Sales by Application (2020-2031)
3.2.1.1 Global Codeine Sales Volume by Application (2020-2031)
3.2.1.2 Global Codeine Sales Market Share by Application (2020-2031)
3.2.2 Global Codeine Revenue by Application (2020-2031)
3.2.2.1 Global Codeine Revenue by Application (2020-2031)
3.2.2.2 Global Codeine Revenue Market Share by Application (2020-2031)
3.2.3 Codeine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Ingredient and by Application Crossing Analysis
3.3.1 Single-ingredient Codeine of Codeine Revenue Market Share by Application
3.3.2 Multi-ingredient Medications of Codeine Revenue Market Share by Application
4 Global Codeine by Manufacturers
4.1 Global Top Codeine Manufacturers by Sales (2020-2025)
4.1.1 Global Codeine Sales by Manufacturer (2020-2025)
4.1.2 Global Codeine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Codeine Manufacturers by Revenue (2020-2025)
4.2.1 Global Codeine Revenue by Manufacturer (2020-2025)
4.2.2 Global Codeine Revenue Share by Manufacturer (2020-2025)
4.3 Global Codeine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Codeine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Codeine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Codeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Codeine Manufacturing Base Distribution, Product Type
4.5.1 Codeine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Codeine Market
4.5.3 Manufacturers Codeine Product Type and Application
4.5.4 Single-ingredient Codeine Market Sales of Codeine by Manufacturer
4.5.5 Multi-ingredient Medications Market Sales of Codeine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Taiji
5.1.1 Taiji Company Information
5.1.2 Taiji Description, Business Overview
5.1.3 Taiji Codeine Products Offered
5.1.4 Taiji Codeine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Taiji Codeine Sales by Product in 2024
5.1.6 Taiji Codeine Sales by Application in 2024
5.1.7 Taiji Codeine Sales by Geographic Area in 2024
5.1.8 Taiji Recent Developments
5.2 Mallinckrodt
5.2.1 Mallinckrodt Company Information
5.2.2 Mallinckrodt Description, Business Overview
5.2.3 Mallinckrodt Codeine Products Offered
5.2.4 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Mallinckrodt Codeine Sales by Product in 2024
5.2.6 Mallinckrodt Codeine Sales by Application in 2024
5.2.7 Mallinckrodt Codeine Sales by Geographic Area in 2024
5.2.8 Mallinckrodt Recent Developments
5.3 TEVA
5.3.1 TEVA Company Information
5.3.2 TEVA Description, Business Overview
5.3.3 TEVA Codeine Products Offered
5.3.4 TEVA Codeine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 TEVA Codeine Sales by Product in 2024
5.3.6 TEVA Codeine Sales by Application in 2024
5.3.7 TEVA Codeine Sales by Geographic Area in 2024
5.3.8 TEVA Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Company Information
5.4.2 Johnson & Johnson Description, Business Overview
5.4.3 Johnson & Johnson Codeine Products Offered
5.4.4 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Johnson & Johnson Codeine Sales by Product in 2024
5.4.6 Johnson & Johnson Codeine Sales by Application in 2024
5.4.7 Johnson & Johnson Codeine Sales by Geographic Area in 2024
5.4.8 Johnson & Johnson Recent Developments
5.5 Medreich
5.5.1 Medreich Company Information
5.5.2 Medreich Description, Business Overview
5.5.3 Medreich Codeine Products Offered
5.5.4 Medreich Codeine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Medreich Codeine Sales by Product in 2024
5.5.6 Medreich Codeine Sales by Application in 2024
5.5.7 Medreich Codeine Sales by Geographic Area in 2024
5.5.8 Medreich Recent Developments
5.6 Sanofi Aventis
5.6.1 Sanofi Aventis Company Information
5.6.2 Sanofi Aventis Description, Business Overview
5.6.3 Sanofi Aventis Codeine Products Offered
5.6.4 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Sanofi Aventis Codeine Sales by Product in 2024
5.6.6 Sanofi Aventis Codeine Sales by Application in 2024
5.6.7 Sanofi Aventis Codeine Sales by Geographic Area in 2024
5.6.8 Sanofi Aventis Recent Developments
5.7 Cipla
5.7.1 Cipla Company Information
5.7.2 Cipla Description, Business Overview
5.7.3 Cipla Codeine Products Offered
5.7.4 Cipla Codeine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Cipla Codeine Sales by Product in 2024
5.7.6 Cipla Codeine Sales by Application in 2024
5.7.7 Cipla Codeine Sales by Geographic Area in 2024
5.7.8 Cipla Recent Developments
5.8 Hikma
5.8.1 Hikma Company Information
5.8.2 Hikma Description, Business Overview
5.8.3 Hikma Codeine Products Offered
5.8.4 Hikma Codeine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Hikma Codeine Sales by Product in 2024
5.8.6 Hikma Codeine Sales by Application in 2024
5.8.7 Hikma Codeine Sales by Geographic Area in 2024
5.8.8 Hikma Recent Developments
5.9 Pharmaceutical Associates
5.9.1 Pharmaceutical Associates Company Information
5.9.2 Pharmaceutical Associates Description, Business Overview
5.9.3 Pharmaceutical Associates Codeine Products Offered
5.9.4 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Pharmaceutical Associates Codeine Sales by Product in 2024
5.9.6 Pharmaceutical Associates Codeine Sales by Application in 2024
5.9.7 Pharmaceutical Associates Codeine Sales by Geographic Area in 2024
5.9.8 Pharmaceutical Associates Recent Developments
5.10 Novartis
5.10.1 Novartis Company Information
5.10.2 Novartis Description, Business Overview
5.10.3 Novartis Codeine Products Offered
5.10.4 Novartis Codeine Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Novartis Codeine Sales by Product in 2024
5.10.6 Novartis Codeine Sales by Application in 2024
5.10.7 Novartis Codeine Sales by Geographic Area in 2024
5.10.8 Novartis Recent Developments
5.11 Apotex
5.11.1 Apotex Company Information
5.11.2 Apotex Description, Business Overview
5.11.3 Apotex Codeine Products Offered
5.11.4 Apotex Codeine Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Apotex Codeine Sales by Product in 2024
5.11.6 Apotex Codeine Sales by Application in 2024
5.11.7 Apotex Codeine Sales by Geographic Area in 2024
5.11.8 Apotex Recent Developments
5.12 Mylan
5.12.1 Mylan Company Information
5.12.2 Mylan Description, Business Overview
5.12.3 Mylan Codeine Products Offered
5.12.4 Mylan Codeine Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Mylan Codeine Sales by Product in 2024
5.12.6 Mylan Codeine Sales by Application in 2024
5.12.7 Mylan Codeine Sales by Geographic Area in 2024
5.12.8 Mylan Recent Developments
5.13 Aristo Pharma GmbH
5.13.1 Aristo Pharma GmbH Company Information
5.13.2 Aristo Pharma GmbH Description, Business Overview
5.13.3 Aristo Pharma GmbH Codeine Products Offered
5.13.4 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Aristo Pharma GmbH Codeine Sales by Product in 2024
5.13.6 Aristo Pharma GmbH Codeine Sales by Application in 2024
5.13.7 Aristo Pharma GmbH Codeine Sales by Geographic Area in 2024
5.13.8 Aristo Pharma GmbH Recent Developments
5.14 Lannett Company
5.14.1 Lannett Company Company Information
5.14.2 Lannett Company Description, Business Overview
5.14.3 Lannett Company Codeine Products Offered
5.14.4 Lannett Company Codeine Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Lannett Company Codeine Sales by Product in 2024
5.14.6 Lannett Company Codeine Sales by Application in 2024
5.14.7 Lannett Company Codeine Sales by Geographic Area in 2024
5.14.8 Lannett Company Recent Developments
5.15 Laboratoire Riva
5.15.1 Laboratoire Riva Company Information
5.15.2 Laboratoire Riva Description, Business Overview
5.15.3 Laboratoire Riva Codeine Products Offered
5.15.4 Laboratoire Riva Codeine Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Laboratoire Riva Codeine Sales by Product in 2024
5.15.6 Laboratoire Riva Codeine Sales by Application in 2024
5.15.7 Laboratoire Riva Codeine Sales by Geographic Area in 2024
5.15.8 Laboratoire Riva Recent Developments
6 North America
6.1 North America Codeine Market Size YoY Growth 2020-2031
6.2 North America Codeine Market Facts & Figures by Country
6.2.1 North America Codeine Sales by Country (2020-2031)
6.2.2 North America Codeine Revenue by Country (2020-2031)
6.3 North America Codeine Sales by Ingredient (2020-2025)
6.4 North America Codeine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Codeine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Codeine Market Facts & Figures by Region
7.2.1 Asia-Pacific Codeine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Codeine Revenue by Region (2020-2031)
7.3 Asia-Pacific Codeine Sales by Ingredient (2020-2025)
7.4 Asia-Pacific Codeine Sales by Application (2020-2025)
8 Europe
8.1 Europe Codeine Market Size YoY Growth 2020-2031
8.2 Europe Codeine Market Facts & Figures by Country
8.2.1 Europe Codeine Sales by Country (2020-2031)
8.2.2 Europe Codeine Revenue by Country (2020-2031)
8.3 Europe Codeine Sales by Ingredient (2020-2025)
8.4 Europe Codeine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Codeine Market Size YoY Growth 2020-2031
9.2 Latin America Codeine Market Facts & Figures by Country
9.2.1 Latin America Codeine Sales by Country (2020-2031)
9.2.2 Latin America Codeine Revenue by Country (2020-2031)
9.3 Latin America Codeine Sales by Ingredient (2020-2025)
9.4 Latin America Codeine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Codeine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Codeine Market Facts & Figures by Country
10.2.1 Middle East and Africa Codeine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Codeine Revenue by Country (2020-2031)
10.3 Middle East and Africa Codeine Sales by Ingredient (2020-2025)
10.4 Middle East and Africa Codeine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Codeine Supply Chain Analysis
11.2 Codeine Key Raw Materials and Upstream Suppliers
11.3 Codeine Clients Analysis
11.4 Codeine Sales Channel and Sales Model Analysis
11.4.1 Codeine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Codeine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Codeine Distributors
12 Codeine Market Dynamics
12.1 Codeine Industry Trends
12.2 Codeine Market Drivers
12.3 Codeine Market Challenges
12.4 Codeine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Codeine Product Introduction
1.2 Market by Ingredient
1.2.1 Global Codeine Market Size Growth Rate by Ingredient (2020 VS 2024 VS 2031)
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Market by Application
1.3.1 Global Codeine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Codeine Market Size Estimates and Forecasts
2.1.1 Global Codeine Revenue 2020-2031
2.1.2 Global Codeine Sales 2020-2031
2.2 Codeine Market Size by Region: 2024 Versus 2031
2.3 Codeine Sales by Region (2020-2031)
2.3.1 Global Codeine Sales by Region: 2020-2025
2.3.2 Global Codeine Sales Forecast by Region (2026-2031)
2.3.3 Global Codeine Sales Market Share by Region (2020-2031)
2.4 Codeine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Codeine Revenue by Region: 2020-2025
2.4.2 Global Codeine Revenue Forecast by Region (2026-2031)
2.4.3 Global Codeine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Ingredient
3.1.1 Global Codeine Sales by Ingredient (2020-2031)
3.1.1.1 Global Codeine Sales Volume by Ingredient (2020-2031)
3.1.1.2 Global Codeine Sales Market Share by Ingredient (2020-2031)
3.1.2 Global Codeine Revenue by Ingredient (2020-2031)
3.1.2.1 Global Codeine Revenue by Ingredient (2020-2031)
3.1.2.2 Global Codeine Revenue Market Share by Ingredient (2020-2031)
3.1.3 Codeine Average Selling Price (ASP) by Ingredient (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Codeine Sales by Application (2020-2031)
3.2.1.1 Global Codeine Sales Volume by Application (2020-2031)
3.2.1.2 Global Codeine Sales Market Share by Application (2020-2031)
3.2.2 Global Codeine Revenue by Application (2020-2031)
3.2.2.1 Global Codeine Revenue by Application (2020-2031)
3.2.2.2 Global Codeine Revenue Market Share by Application (2020-2031)
3.2.3 Codeine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Ingredient and by Application Crossing Analysis
3.3.1 Single-ingredient Codeine of Codeine Revenue Market Share by Application
3.3.2 Multi-ingredient Medications of Codeine Revenue Market Share by Application
4 Global Codeine by Manufacturers
4.1 Global Top Codeine Manufacturers by Sales (2020-2025)
4.1.1 Global Codeine Sales by Manufacturer (2020-2025)
4.1.2 Global Codeine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Codeine Manufacturers by Revenue (2020-2025)
4.2.1 Global Codeine Revenue by Manufacturer (2020-2025)
4.2.2 Global Codeine Revenue Share by Manufacturer (2020-2025)
4.3 Global Codeine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Codeine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Codeine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Codeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Codeine Manufacturing Base Distribution, Product Type
4.5.1 Codeine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Codeine Market
4.5.3 Manufacturers Codeine Product Type and Application
4.5.4 Single-ingredient Codeine Market Sales of Codeine by Manufacturer
4.5.5 Multi-ingredient Medications Market Sales of Codeine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Taiji
5.1.1 Taiji Company Information
5.1.2 Taiji Description, Business Overview
5.1.3 Taiji Codeine Products Offered
5.1.4 Taiji Codeine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Taiji Codeine Sales by Product in 2024
5.1.6 Taiji Codeine Sales by Application in 2024
5.1.7 Taiji Codeine Sales by Geographic Area in 2024
5.1.8 Taiji Recent Developments
5.2 Mallinckrodt
5.2.1 Mallinckrodt Company Information
5.2.2 Mallinckrodt Description, Business Overview
5.2.3 Mallinckrodt Codeine Products Offered
5.2.4 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Mallinckrodt Codeine Sales by Product in 2024
5.2.6 Mallinckrodt Codeine Sales by Application in 2024
5.2.7 Mallinckrodt Codeine Sales by Geographic Area in 2024
5.2.8 Mallinckrodt Recent Developments
5.3 TEVA
5.3.1 TEVA Company Information
5.3.2 TEVA Description, Business Overview
5.3.3 TEVA Codeine Products Offered
5.3.4 TEVA Codeine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 TEVA Codeine Sales by Product in 2024
5.3.6 TEVA Codeine Sales by Application in 2024
5.3.7 TEVA Codeine Sales by Geographic Area in 2024
5.3.8 TEVA Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Company Information
5.4.2 Johnson & Johnson Description, Business Overview
5.4.3 Johnson & Johnson Codeine Products Offered
5.4.4 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Johnson & Johnson Codeine Sales by Product in 2024
5.4.6 Johnson & Johnson Codeine Sales by Application in 2024
5.4.7 Johnson & Johnson Codeine Sales by Geographic Area in 2024
5.4.8 Johnson & Johnson Recent Developments
5.5 Medreich
5.5.1 Medreich Company Information
5.5.2 Medreich Description, Business Overview
5.5.3 Medreich Codeine Products Offered
5.5.4 Medreich Codeine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Medreich Codeine Sales by Product in 2024
5.5.6 Medreich Codeine Sales by Application in 2024
5.5.7 Medreich Codeine Sales by Geographic Area in 2024
5.5.8 Medreich Recent Developments
5.6 Sanofi Aventis
5.6.1 Sanofi Aventis Company Information
5.6.2 Sanofi Aventis Description, Business Overview
5.6.3 Sanofi Aventis Codeine Products Offered
5.6.4 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Sanofi Aventis Codeine Sales by Product in 2024
5.6.6 Sanofi Aventis Codeine Sales by Application in 2024
5.6.7 Sanofi Aventis Codeine Sales by Geographic Area in 2024
5.6.8 Sanofi Aventis Recent Developments
5.7 Cipla
5.7.1 Cipla Company Information
5.7.2 Cipla Description, Business Overview
5.7.3 Cipla Codeine Products Offered
5.7.4 Cipla Codeine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Cipla Codeine Sales by Product in 2024
5.7.6 Cipla Codeine Sales by Application in 2024
5.7.7 Cipla Codeine Sales by Geographic Area in 2024
5.7.8 Cipla Recent Developments
5.8 Hikma
5.8.1 Hikma Company Information
5.8.2 Hikma Description, Business Overview
5.8.3 Hikma Codeine Products Offered
5.8.4 Hikma Codeine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Hikma Codeine Sales by Product in 2024
5.8.6 Hikma Codeine Sales by Application in 2024
5.8.7 Hikma Codeine Sales by Geographic Area in 2024
5.8.8 Hikma Recent Developments
5.9 Pharmaceutical Associates
5.9.1 Pharmaceutical Associates Company Information
5.9.2 Pharmaceutical Associates Description, Business Overview
5.9.3 Pharmaceutical Associates Codeine Products Offered
5.9.4 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Pharmaceutical Associates Codeine Sales by Product in 2024
5.9.6 Pharmaceutical Associates Codeine Sales by Application in 2024
5.9.7 Pharmaceutical Associates Codeine Sales by Geographic Area in 2024
5.9.8 Pharmaceutical Associates Recent Developments
5.10 Novartis
5.10.1 Novartis Company Information
5.10.2 Novartis Description, Business Overview
5.10.3 Novartis Codeine Products Offered
5.10.4 Novartis Codeine Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Novartis Codeine Sales by Product in 2024
5.10.6 Novartis Codeine Sales by Application in 2024
5.10.7 Novartis Codeine Sales by Geographic Area in 2024
5.10.8 Novartis Recent Developments
5.11 Apotex
5.11.1 Apotex Company Information
5.11.2 Apotex Description, Business Overview
5.11.3 Apotex Codeine Products Offered
5.11.4 Apotex Codeine Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Apotex Codeine Sales by Product in 2024
5.11.6 Apotex Codeine Sales by Application in 2024
5.11.7 Apotex Codeine Sales by Geographic Area in 2024
5.11.8 Apotex Recent Developments
5.12 Mylan
5.12.1 Mylan Company Information
5.12.2 Mylan Description, Business Overview
5.12.3 Mylan Codeine Products Offered
5.12.4 Mylan Codeine Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Mylan Codeine Sales by Product in 2024
5.12.6 Mylan Codeine Sales by Application in 2024
5.12.7 Mylan Codeine Sales by Geographic Area in 2024
5.12.8 Mylan Recent Developments
5.13 Aristo Pharma GmbH
5.13.1 Aristo Pharma GmbH Company Information
5.13.2 Aristo Pharma GmbH Description, Business Overview
5.13.3 Aristo Pharma GmbH Codeine Products Offered
5.13.4 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Aristo Pharma GmbH Codeine Sales by Product in 2024
5.13.6 Aristo Pharma GmbH Codeine Sales by Application in 2024
5.13.7 Aristo Pharma GmbH Codeine Sales by Geographic Area in 2024
5.13.8 Aristo Pharma GmbH Recent Developments
5.14 Lannett Company
5.14.1 Lannett Company Company Information
5.14.2 Lannett Company Description, Business Overview
5.14.3 Lannett Company Codeine Products Offered
5.14.4 Lannett Company Codeine Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Lannett Company Codeine Sales by Product in 2024
5.14.6 Lannett Company Codeine Sales by Application in 2024
5.14.7 Lannett Company Codeine Sales by Geographic Area in 2024
5.14.8 Lannett Company Recent Developments
5.15 Laboratoire Riva
5.15.1 Laboratoire Riva Company Information
5.15.2 Laboratoire Riva Description, Business Overview
5.15.3 Laboratoire Riva Codeine Products Offered
5.15.4 Laboratoire Riva Codeine Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Laboratoire Riva Codeine Sales by Product in 2024
5.15.6 Laboratoire Riva Codeine Sales by Application in 2024
5.15.7 Laboratoire Riva Codeine Sales by Geographic Area in 2024
5.15.8 Laboratoire Riva Recent Developments
6 North America
6.1 North America Codeine Market Size YoY Growth 2020-2031
6.2 North America Codeine Market Facts & Figures by Country
6.2.1 North America Codeine Sales by Country (2020-2031)
6.2.2 North America Codeine Revenue by Country (2020-2031)
6.3 North America Codeine Sales by Ingredient (2020-2025)
6.4 North America Codeine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Codeine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Codeine Market Facts & Figures by Region
7.2.1 Asia-Pacific Codeine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Codeine Revenue by Region (2020-2031)
7.3 Asia-Pacific Codeine Sales by Ingredient (2020-2025)
7.4 Asia-Pacific Codeine Sales by Application (2020-2025)
8 Europe
8.1 Europe Codeine Market Size YoY Growth 2020-2031
8.2 Europe Codeine Market Facts & Figures by Country
8.2.1 Europe Codeine Sales by Country (2020-2031)
8.2.2 Europe Codeine Revenue by Country (2020-2031)
8.3 Europe Codeine Sales by Ingredient (2020-2025)
8.4 Europe Codeine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Codeine Market Size YoY Growth 2020-2031
9.2 Latin America Codeine Market Facts & Figures by Country
9.2.1 Latin America Codeine Sales by Country (2020-2031)
9.2.2 Latin America Codeine Revenue by Country (2020-2031)
9.3 Latin America Codeine Sales by Ingredient (2020-2025)
9.4 Latin America Codeine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Codeine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Codeine Market Facts & Figures by Country
10.2.1 Middle East and Africa Codeine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Codeine Revenue by Country (2020-2031)
10.3 Middle East and Africa Codeine Sales by Ingredient (2020-2025)
10.4 Middle East and Africa Codeine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Codeine Supply Chain Analysis
11.2 Codeine Key Raw Materials and Upstream Suppliers
11.3 Codeine Clients Analysis
11.4 Codeine Sales Channel and Sales Model Analysis
11.4.1 Codeine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Codeine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Codeine Distributors
12 Codeine Market Dynamics
12.1 Codeine Industry Trends
12.2 Codeine Market Drivers
12.3 Codeine Market Challenges
12.4 Codeine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Codeine Market Size Growth Rate by Ingredient (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Codeine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Codeine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Codeine Sales by Region (2020-2025) & (M Units)
Table 5. Global Codeine Sales Forecast by Region (2026-2031) & (M Units)
Table 6. Global Codeine Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Codeine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Codeine Sales Volume by Ingredient (2020-2025) & (M Units)
Table 9. Global Codeine Sales Volume by Ingredient (2026-2031) & (M Units)
Table 10. Global Codeine Revenue by Ingredient (2020-2025) & (US$ Million)
Table 11. Global Codeine Revenue Forecast by Ingredient (2026-2031) & (US$ Million)
Table 12. Global Codeine Sales Volume by Application (2020-2025) & (M Units)
Table 13. Global Codeine Sales Volume by Application (2026-2031) & (M Units)
Table 14. Global Codeine Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Codeine Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Codeine Sales by Manufacturer (2020-2025) & (M Units)
Table 17. Global Codeine Sales Share by Manufacturer (2020-2025)
Table 18. Codeine Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Codeine Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Codeine Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Codeine Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Codeine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Codeine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Codeine as of 2024)
Table 24. Codeine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Codeine Market
Table 26. Manufacturers Codeine Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Taiji Company Information
Table 29. Taiji Description and Business Overview
Table 30. Taiji Codeine Product
Table 31. Taiji Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Taiji Sales Proportion of Codeine by Product in 2024
Table 33. Taiji Sales Proportion of Codeine by Application in 2024
Table 34. Taiji Sales Proportion of Codeine by Geographic Area in 2024
Table 35. Taiji Recent Developments
Table 36. Mallinckrodt Company Information
Table 37. Mallinckrodt Description and Business Overview
Table 38. Mallinckrodt Codeine Product
Table 39. Mallinckrodt Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Mallinckrodt Sales Proportion of Codeine by Product in 2024
Table 41. Mallinckrodt Sales Proportion of Codeine by Application in 2024
Table 42. Mallinckrodt Sales Proportion of Codeine by Geographic Area in 2024
Table 43. Mallinckrodt Recent Developments
Table 44. TEVA Company Information
Table 45. TEVA Description and Business Overview
Table 46. TEVA Codeine Product
Table 47. TEVA Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. TEVA Sales Proportion of Codeine by Product in 2024
Table 49. TEVA Sales Proportion of Codeine by Application in 2024
Table 50. TEVA Sales Proportion of Codeine by Geographic Area in 2024
Table 51. TEVA Recent Developments
Table 52. Johnson & Johnson Company Information
Table 53. Johnson & Johnson Description and Business Overview
Table 54. Johnson & Johnson Codeine Product
Table 55. Johnson & Johnson Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Johnson & Johnson Sales Proportion of Codeine by Product in 2024
Table 57. Johnson & Johnson Sales Proportion of Codeine by Application in 2024
Table 58. Johnson & Johnson Sales Proportion of Codeine by Geographic Area in 2024
Table 59. Johnson & Johnson Recent Developments
Table 60. Medreich Company Information
Table 61. Medreich Description and Business Overview
Table 62. Medreich Codeine Product
Table 63. Medreich Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Medreich Sales Proportion of Codeine by Product in 2024
Table 65. Medreich Sales Proportion of Codeine by Application in 2024
Table 66. Medreich Sales Proportion of Codeine by Geographic Area in 2024
Table 67. Medreich Recent Developments
Table 68. Sanofi Aventis Company Information
Table 69. Sanofi Aventis Description and Business Overview
Table 70. Sanofi Aventis Codeine Product
Table 71. Sanofi Aventis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Sanofi Aventis Sales Proportion of Codeine by Product in 2024
Table 73. Sanofi Aventis Sales Proportion of Codeine by Application in 2024
Table 74. Sanofi Aventis Sales Proportion of Codeine by Geographic Area in 2024
Table 75. Sanofi Aventis Recent Developments
Table 76. Cipla Company Information
Table 77. Cipla Description and Business Overview
Table 78. Cipla Codeine Product
Table 79. Cipla Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Cipla Sales Proportion of Codeine by Product in 2024
Table 81. Cipla Sales Proportion of Codeine by Application in 2024
Table 82. Cipla Sales Proportion of Codeine by Geographic Area in 2024
Table 83. Cipla Recent Developments
Table 84. Hikma Company Information
Table 85. Hikma Description and Business Overview
Table 86. Hikma Codeine Product
Table 87. Hikma Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Hikma Sales Proportion of Codeine by Product in 2024
Table 89. Hikma Sales Proportion of Codeine by Application in 2024
Table 90. Hikma Sales Proportion of Codeine by Geographic Area in 2024
Table 91. Hikma Recent Developments
Table 92. Pharmaceutical Associates Company Information
Table 93. Pharmaceutical Associates Description and Business Overview
Table 94. Pharmaceutical Associates Codeine Product
Table 95. Pharmaceutical Associates Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Pharmaceutical Associates Sales Proportion of Codeine by Product in 2024
Table 97. Pharmaceutical Associates Sales Proportion of Codeine by Application in 2024
Table 98. Pharmaceutical Associates Sales Proportion of Codeine by Geographic Area in 2024
Table 99. Pharmaceutical Associates Recent Developments
Table 100. Novartis Company Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Codeine Product
Table 103. Novartis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Novartis Sales Proportion of Codeine by Product in 2024
Table 105. Novartis Sales Proportion of Codeine by Application in 2024
Table 106. Novartis Sales Proportion of Codeine by Geographic Area in 2024
Table 107. Novartis Recent Developments
Table 108. Apotex Company Information
Table 109. Apotex Description and Business Overview
Table 110. Apotex Codeine Product
Table 111. Apotex Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Apotex Sales Proportion of Codeine by Product in 2024
Table 113. Apotex Sales Proportion of Codeine by Application in 2024
Table 114. Apotex Sales Proportion of Codeine by Geographic Area in 2024
Table 115. Apotex Recent Developments
Table 116. Mylan Company Information
Table 117. Mylan Description and Business Overview
Table 118. Mylan Codeine Product
Table 119. Mylan Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Mylan Sales Proportion of Codeine by Product in 2024
Table 121. Mylan Sales Proportion of Codeine by Application in 2024
Table 122. Mylan Sales Proportion of Codeine by Geographic Area in 2024
Table 123. Mylan Recent Developments
Table 124. Aristo Pharma GmbH Company Information
Table 125. Aristo Pharma GmbH Description and Business Overview
Table 126. Aristo Pharma GmbH Codeine Product
Table 127. Aristo Pharma GmbH Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Aristo Pharma GmbH Sales Proportion of Codeine by Product in 2024
Table 129. Aristo Pharma GmbH Sales Proportion of Codeine by Application in 2024
Table 130. Aristo Pharma GmbH Sales Proportion of Codeine by Geographic Area in 2024
Table 131. Aristo Pharma GmbH Recent Developments
Table 132. Lannett Company Company Information
Table 133. Lannett Company Description and Business Overview
Table 134. Lannett Company Codeine Product
Table 135. Lannett Company Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Lannett Company Sales Proportion of Codeine by Product in 2024
Table 137. Lannett Company Sales Proportion of Codeine by Application in 2024
Table 138. Lannett Company Sales Proportion of Codeine by Geographic Area in 2024
Table 139. Lannett Company Recent Developments
Table 140. Laboratoire Riva Company Information
Table 141. Laboratoire Riva Description and Business Overview
Table 142. Laboratoire Riva Codeine Product
Table 143. Laboratoire Riva Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 144. Laboratoire Riva Sales Proportion of Codeine by Product in 2024
Table 145. Laboratoire Riva Sales Proportion of Codeine by Application in 2024
Table 146. Laboratoire Riva Sales Proportion of Codeine by Geographic Area in 2024
Table 147. Laboratoire Riva Recent Developments
Table 148. North America Codeine Sales by Country (2020-2025) & (M Units)
Table 149. North America Codeine Sales by Country (2026-2031) & (M Units)
Table 150. North America Codeine Revenue by Country (2020-2025) & (US$ Million)
Table 151. North America Codeine Revenue by Country (2026-2031) & (US$ Million)
Table 152. North America Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 153. North America Codeine Sales by Application (2020-2025) & (M Units)
Table 154. Asia-Pacific Codeine Sales by Region (2020-2025) & (M Units)
Table 155. Asia-Pacific Codeine Sales by Region (2026-2031) & (M Units)
Table 156. Asia-Pacific Codeine Revenue by Region (2020-2025) & (US$ Million)
Table 157. Asia-Pacific Codeine Revenue by Region (2026-2031) & (US$ Million)
Table 158. Asia-Pacific Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 159. Asia-Pacific Codeine Sales by Application (2020-2025) & (M Units)
Table 160. Europe Codeine Sales by Country (2020-2025) & (M Units)
Table 161. Europe Codeine Sales by Country (2026-2031) & (M Units)
Table 162. Europe Codeine Revenue by Country (2020-2025) & (US$ Million)
Table 163. Europe Codeine Revenue by Country (2026-2031) & (US$ Million)
Table 164. Europe Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 165. Europe Codeine Sales by Application (2020-2025) & (M Units)
Table 166. Latin America Codeine Sales by Country (2020-2025) & (M Units)
Table 167. Latin America Codeine Sales by Country (2026-2031) & (M Units)
Table 168. Latin America Codeine Revenue by Country (2020-2025) & (US$ Million)
Table 169. Latin America Codeine Revenue by Country (2026-2031) & (US$ Million)
Table 170. Latin America Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 171. Latin America Codeine Sales by Application (2020-2025) & (M Units)
Table 172. Middle East and Africa Codeine Sales by Country (2020-2025) & (M Units)
Table 173. Middle East and Africa Codeine Sales by Country (2026-2031) & (M Units)
Table 174. Middle East and Africa Codeine Revenue by Country (2020-2025) & (US$ Million)
Table 175. Middle East and Africa Codeine Revenue by Country (2026-2031) & (US$ Million)
Table 176. Middle East and Africa Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 177. Middle East and Africa Codeine Sales by Application (2020-2025) & (M Units)
Table 178. Codeine Key Raw Materials, Industry Status and Trend
Table 179. Codeine Key Raw Materials and Upstream Suppliers
Table 180. Codeine Clients Status and Trend
Table 181. Codeine Typical Clients
Table 182. Codeine Distributors
Table 183. Codeine Market Trends
Table 184. Codeine Market Drivers
Table 185. Codeine Market Challenges
Table 186. Codeine Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
Table 190. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Codeine Product Picture
Figure 2. Global Codeine Market Size by Ingredient (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Codeine Sales Market Share by Ingredient in 2024 & 2031
Figure 4. Single-ingredient Codeine Product Picture
Figure 5. Multi-ingredient Medications Product Picture
Figure 6. Global Codeine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Codeine Sales Market Share by Application in 2024 & 2031
Figure 8. Narcotic Analgesic
Figure 9. Antitussive
Figure 10. Others
Figure 11. Codeine Report Years Considered
Figure 12. Global Codeine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Codeine Market Size 2020-2031 (US$ Million)
Figure 14. Global Codeine Sales 2020-2031 (M Units)
Figure 15. Global Codeine Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Codeine Revenue Market Share by Region (2020-2031)
Figure 17. Global Codeine Sales Market Share Forecast by Ingredient (2020-2031)
Figure 18. Global Codeine Revenue Market Share Forecast by Ingredient (2020-2031)
Figure 19. Codeine Average Selling Price (ASP) by Ingredient (2020-2025) & (USD/Unit)
Figure 20. Global Codeine Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Codeine Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Codeine Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 23. Single-ingredient Codeine of Codeine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Multi-ingredient Medications of Codeine Revenue Market Share by Application, 2024 VS 2031
Figure 25. Global Codeine Sales Share by Manufacturer in 2024
Figure 26. Codeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Single-ingredient Codeine Market Sales Proportion by Manufacturer in 2024
Figure 28. Multi-ingredient Medications Market Sales Proportion by Manufacturer in 2024
Figure 29. North America Codeine Revenue 2020-2031 (US$ Million)
Figure 30. North America Codeine Sales Market Share by Ingredient (2020-2025)
Figure 31. North America Codeine Sales Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Codeine Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Codeine Sales Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Codeine Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Codeine Sales Market Share by Ingredient (2020-2025)
Figure 36. Asia-Pacific Codeine Sales Market Share by Application (2020-2025)
Figure 37. Europe Codeine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Codeine Sales Market Share by Country (2020-2031)
Figure 39. Europe Codeine Revenue Market Share by Country (2020-2031)
Figure 40. Europe Codeine Sales Market Share by Ingredient (2020-2025)
Figure 41. Europe Codeine Sales Market Share by Application (2020-2025)
Figure 42. Latin America Codeine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Codeine Sales Market Share by Country (2020-2031)
Figure 44. Latin America Codeine Revenue Market Share by Country (2020-2025)
Figure 45. Latin America Codeine Sales Market Share by Ingredient (2020-2025)
Figure 46. Latin America Codeine Sales Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Codeine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Codeine Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Codeine Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Codeine Sales Market Share by Ingredient (2020-2025)
Figure 51. Middle East and Africa Codeine Sales Market Share by Application (2020-2025)
Figure 52. Codeine Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Codeine Raw Materials by Region in 2024
Figure 54. Codeine Distribution Channels
Figure 55. Global Codeine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Codeine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Codeine Market Size Growth Rate by Ingredient (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Codeine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Codeine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Codeine Sales by Region (2020-2025) & (M Units)
Table 5. Global Codeine Sales Forecast by Region (2026-2031) & (M Units)
Table 6. Global Codeine Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Codeine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Codeine Sales Volume by Ingredient (2020-2025) & (M Units)
Table 9. Global Codeine Sales Volume by Ingredient (2026-2031) & (M Units)
Table 10. Global Codeine Revenue by Ingredient (2020-2025) & (US$ Million)
Table 11. Global Codeine Revenue Forecast by Ingredient (2026-2031) & (US$ Million)
Table 12. Global Codeine Sales Volume by Application (2020-2025) & (M Units)
Table 13. Global Codeine Sales Volume by Application (2026-2031) & (M Units)
Table 14. Global Codeine Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Codeine Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Codeine Sales by Manufacturer (2020-2025) & (M Units)
Table 17. Global Codeine Sales Share by Manufacturer (2020-2025)
Table 18. Codeine Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Codeine Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Codeine Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Codeine Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Codeine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Codeine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Codeine as of 2024)
Table 24. Codeine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Codeine Market
Table 26. Manufacturers Codeine Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Taiji Company Information
Table 29. Taiji Description and Business Overview
Table 30. Taiji Codeine Product
Table 31. Taiji Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Taiji Sales Proportion of Codeine by Product in 2024
Table 33. Taiji Sales Proportion of Codeine by Application in 2024
Table 34. Taiji Sales Proportion of Codeine by Geographic Area in 2024
Table 35. Taiji Recent Developments
Table 36. Mallinckrodt Company Information
Table 37. Mallinckrodt Description and Business Overview
Table 38. Mallinckrodt Codeine Product
Table 39. Mallinckrodt Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Mallinckrodt Sales Proportion of Codeine by Product in 2024
Table 41. Mallinckrodt Sales Proportion of Codeine by Application in 2024
Table 42. Mallinckrodt Sales Proportion of Codeine by Geographic Area in 2024
Table 43. Mallinckrodt Recent Developments
Table 44. TEVA Company Information
Table 45. TEVA Description and Business Overview
Table 46. TEVA Codeine Product
Table 47. TEVA Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. TEVA Sales Proportion of Codeine by Product in 2024
Table 49. TEVA Sales Proportion of Codeine by Application in 2024
Table 50. TEVA Sales Proportion of Codeine by Geographic Area in 2024
Table 51. TEVA Recent Developments
Table 52. Johnson & Johnson Company Information
Table 53. Johnson & Johnson Description and Business Overview
Table 54. Johnson & Johnson Codeine Product
Table 55. Johnson & Johnson Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Johnson & Johnson Sales Proportion of Codeine by Product in 2024
Table 57. Johnson & Johnson Sales Proportion of Codeine by Application in 2024
Table 58. Johnson & Johnson Sales Proportion of Codeine by Geographic Area in 2024
Table 59. Johnson & Johnson Recent Developments
Table 60. Medreich Company Information
Table 61. Medreich Description and Business Overview
Table 62. Medreich Codeine Product
Table 63. Medreich Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Medreich Sales Proportion of Codeine by Product in 2024
Table 65. Medreich Sales Proportion of Codeine by Application in 2024
Table 66. Medreich Sales Proportion of Codeine by Geographic Area in 2024
Table 67. Medreich Recent Developments
Table 68. Sanofi Aventis Company Information
Table 69. Sanofi Aventis Description and Business Overview
Table 70. Sanofi Aventis Codeine Product
Table 71. Sanofi Aventis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Sanofi Aventis Sales Proportion of Codeine by Product in 2024
Table 73. Sanofi Aventis Sales Proportion of Codeine by Application in 2024
Table 74. Sanofi Aventis Sales Proportion of Codeine by Geographic Area in 2024
Table 75. Sanofi Aventis Recent Developments
Table 76. Cipla Company Information
Table 77. Cipla Description and Business Overview
Table 78. Cipla Codeine Product
Table 79. Cipla Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Cipla Sales Proportion of Codeine by Product in 2024
Table 81. Cipla Sales Proportion of Codeine by Application in 2024
Table 82. Cipla Sales Proportion of Codeine by Geographic Area in 2024
Table 83. Cipla Recent Developments
Table 84. Hikma Company Information
Table 85. Hikma Description and Business Overview
Table 86. Hikma Codeine Product
Table 87. Hikma Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Hikma Sales Proportion of Codeine by Product in 2024
Table 89. Hikma Sales Proportion of Codeine by Application in 2024
Table 90. Hikma Sales Proportion of Codeine by Geographic Area in 2024
Table 91. Hikma Recent Developments
Table 92. Pharmaceutical Associates Company Information
Table 93. Pharmaceutical Associates Description and Business Overview
Table 94. Pharmaceutical Associates Codeine Product
Table 95. Pharmaceutical Associates Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Pharmaceutical Associates Sales Proportion of Codeine by Product in 2024
Table 97. Pharmaceutical Associates Sales Proportion of Codeine by Application in 2024
Table 98. Pharmaceutical Associates Sales Proportion of Codeine by Geographic Area in 2024
Table 99. Pharmaceutical Associates Recent Developments
Table 100. Novartis Company Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Codeine Product
Table 103. Novartis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Novartis Sales Proportion of Codeine by Product in 2024
Table 105. Novartis Sales Proportion of Codeine by Application in 2024
Table 106. Novartis Sales Proportion of Codeine by Geographic Area in 2024
Table 107. Novartis Recent Developments
Table 108. Apotex Company Information
Table 109. Apotex Description and Business Overview
Table 110. Apotex Codeine Product
Table 111. Apotex Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Apotex Sales Proportion of Codeine by Product in 2024
Table 113. Apotex Sales Proportion of Codeine by Application in 2024
Table 114. Apotex Sales Proportion of Codeine by Geographic Area in 2024
Table 115. Apotex Recent Developments
Table 116. Mylan Company Information
Table 117. Mylan Description and Business Overview
Table 118. Mylan Codeine Product
Table 119. Mylan Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Mylan Sales Proportion of Codeine by Product in 2024
Table 121. Mylan Sales Proportion of Codeine by Application in 2024
Table 122. Mylan Sales Proportion of Codeine by Geographic Area in 2024
Table 123. Mylan Recent Developments
Table 124. Aristo Pharma GmbH Company Information
Table 125. Aristo Pharma GmbH Description and Business Overview
Table 126. Aristo Pharma GmbH Codeine Product
Table 127. Aristo Pharma GmbH Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Aristo Pharma GmbH Sales Proportion of Codeine by Product in 2024
Table 129. Aristo Pharma GmbH Sales Proportion of Codeine by Application in 2024
Table 130. Aristo Pharma GmbH Sales Proportion of Codeine by Geographic Area in 2024
Table 131. Aristo Pharma GmbH Recent Developments
Table 132. Lannett Company Company Information
Table 133. Lannett Company Description and Business Overview
Table 134. Lannett Company Codeine Product
Table 135. Lannett Company Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Lannett Company Sales Proportion of Codeine by Product in 2024
Table 137. Lannett Company Sales Proportion of Codeine by Application in 2024
Table 138. Lannett Company Sales Proportion of Codeine by Geographic Area in 2024
Table 139. Lannett Company Recent Developments
Table 140. Laboratoire Riva Company Information
Table 141. Laboratoire Riva Description and Business Overview
Table 142. Laboratoire Riva Codeine Product
Table 143. Laboratoire Riva Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 144. Laboratoire Riva Sales Proportion of Codeine by Product in 2024
Table 145. Laboratoire Riva Sales Proportion of Codeine by Application in 2024
Table 146. Laboratoire Riva Sales Proportion of Codeine by Geographic Area in 2024
Table 147. Laboratoire Riva Recent Developments
Table 148. North America Codeine Sales by Country (2020-2025) & (M Units)
Table 149. North America Codeine Sales by Country (2026-2031) & (M Units)
Table 150. North America Codeine Revenue by Country (2020-2025) & (US$ Million)
Table 151. North America Codeine Revenue by Country (2026-2031) & (US$ Million)
Table 152. North America Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 153. North America Codeine Sales by Application (2020-2025) & (M Units)
Table 154. Asia-Pacific Codeine Sales by Region (2020-2025) & (M Units)
Table 155. Asia-Pacific Codeine Sales by Region (2026-2031) & (M Units)
Table 156. Asia-Pacific Codeine Revenue by Region (2020-2025) & (US$ Million)
Table 157. Asia-Pacific Codeine Revenue by Region (2026-2031) & (US$ Million)
Table 158. Asia-Pacific Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 159. Asia-Pacific Codeine Sales by Application (2020-2025) & (M Units)
Table 160. Europe Codeine Sales by Country (2020-2025) & (M Units)
Table 161. Europe Codeine Sales by Country (2026-2031) & (M Units)
Table 162. Europe Codeine Revenue by Country (2020-2025) & (US$ Million)
Table 163. Europe Codeine Revenue by Country (2026-2031) & (US$ Million)
Table 164. Europe Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 165. Europe Codeine Sales by Application (2020-2025) & (M Units)
Table 166. Latin America Codeine Sales by Country (2020-2025) & (M Units)
Table 167. Latin America Codeine Sales by Country (2026-2031) & (M Units)
Table 168. Latin America Codeine Revenue by Country (2020-2025) & (US$ Million)
Table 169. Latin America Codeine Revenue by Country (2026-2031) & (US$ Million)
Table 170. Latin America Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 171. Latin America Codeine Sales by Application (2020-2025) & (M Units)
Table 172. Middle East and Africa Codeine Sales by Country (2020-2025) & (M Units)
Table 173. Middle East and Africa Codeine Sales by Country (2026-2031) & (M Units)
Table 174. Middle East and Africa Codeine Revenue by Country (2020-2025) & (US$ Million)
Table 175. Middle East and Africa Codeine Revenue by Country (2026-2031) & (US$ Million)
Table 176. Middle East and Africa Codeine Sales by Ingredient (2020-2025) & (M Units)
Table 177. Middle East and Africa Codeine Sales by Application (2020-2025) & (M Units)
Table 178. Codeine Key Raw Materials, Industry Status and Trend
Table 179. Codeine Key Raw Materials and Upstream Suppliers
Table 180. Codeine Clients Status and Trend
Table 181. Codeine Typical Clients
Table 182. Codeine Distributors
Table 183. Codeine Market Trends
Table 184. Codeine Market Drivers
Table 185. Codeine Market Challenges
Table 186. Codeine Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
Table 190. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Codeine Product Picture
Figure 2. Global Codeine Market Size by Ingredient (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Codeine Sales Market Share by Ingredient in 2024 & 2031
Figure 4. Single-ingredient Codeine Product Picture
Figure 5. Multi-ingredient Medications Product Picture
Figure 6. Global Codeine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Codeine Sales Market Share by Application in 2024 & 2031
Figure 8. Narcotic Analgesic
Figure 9. Antitussive
Figure 10. Others
Figure 11. Codeine Report Years Considered
Figure 12. Global Codeine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Codeine Market Size 2020-2031 (US$ Million)
Figure 14. Global Codeine Sales 2020-2031 (M Units)
Figure 15. Global Codeine Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Codeine Revenue Market Share by Region (2020-2031)
Figure 17. Global Codeine Sales Market Share Forecast by Ingredient (2020-2031)
Figure 18. Global Codeine Revenue Market Share Forecast by Ingredient (2020-2031)
Figure 19. Codeine Average Selling Price (ASP) by Ingredient (2020-2025) & (USD/Unit)
Figure 20. Global Codeine Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Codeine Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Codeine Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 23. Single-ingredient Codeine of Codeine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Multi-ingredient Medications of Codeine Revenue Market Share by Application, 2024 VS 2031
Figure 25. Global Codeine Sales Share by Manufacturer in 2024
Figure 26. Codeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Single-ingredient Codeine Market Sales Proportion by Manufacturer in 2024
Figure 28. Multi-ingredient Medications Market Sales Proportion by Manufacturer in 2024
Figure 29. North America Codeine Revenue 2020-2031 (US$ Million)
Figure 30. North America Codeine Sales Market Share by Ingredient (2020-2025)
Figure 31. North America Codeine Sales Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Codeine Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Codeine Sales Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Codeine Revenue Market Share by Region (2020-2031)
Figure 35. Asia-Pacific Codeine Sales Market Share by Ingredient (2020-2025)
Figure 36. Asia-Pacific Codeine Sales Market Share by Application (2020-2025)
Figure 37. Europe Codeine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Europe Codeine Sales Market Share by Country (2020-2031)
Figure 39. Europe Codeine Revenue Market Share by Country (2020-2031)
Figure 40. Europe Codeine Sales Market Share by Ingredient (2020-2025)
Figure 41. Europe Codeine Sales Market Share by Application (2020-2025)
Figure 42. Latin America Codeine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Latin America Codeine Sales Market Share by Country (2020-2031)
Figure 44. Latin America Codeine Revenue Market Share by Country (2020-2025)
Figure 45. Latin America Codeine Sales Market Share by Ingredient (2020-2025)
Figure 46. Latin America Codeine Sales Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Codeine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Codeine Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Codeine Revenue Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Codeine Sales Market Share by Ingredient (2020-2025)
Figure 51. Middle East and Africa Codeine Sales Market Share by Application (2020-2025)
Figure 52. Codeine Supply Chain (Upstream and Downstream Market)
Figure 53. Global Production Market Share of Codeine Raw Materials by Region in 2024
Figure 54. Codeine Distribution Channels
Figure 55. Global Codeine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 56. Global Codeine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232